Amgen Inc. is an American multinational biopharmaceutical company headquartered in Thousand Oaks, California. One of the worlds largest independent biotechnology companies, Amgen was established in Thousand Oaks, California, in 1980.
Financial Statements
- Click here to download AMGEN Inc.'s Income Statement
- Click here to download AMGEN Inc.'s Balance Sheet
- Click here to download AMGEN Inc.'s Statement of Cash Flows
Key Info
- Industry: Biological Product (except Diagnostic) Manufacturing
- Sector: Manufacturing
- CEO Name: Robert Bradway
Key Statistics
- Stock Price: $284.32
- Dividend Yield: 3.0%
- Market Capitalization: $152,372,461,932
- Shares Outstanding: 535,918,901
- Number of Employees: 25,200
- Trailing 12-Month EPS: $12.49
- Trailing 12-Month DPS: $8.46
- Payout Ratio: 67.7%
Important Dates
- Next Earnings Date: 2024-05-02
- Next Ex-Dividend Date: 2024-02-15
Price Trends
- Current Stock Price: $284.32
- 52-week high: $324.63
- 52-week low: $203.55
- 200-day moving average: $276.22
- 50-day moving average: $279.4
Performance
- 1-Month Price Return: 2.5%
- 3-Month Price Return: 0.3%
- 6-Month Price Return: 9.1%
- 1-Year Price Return: 23.6%
- 2-Year Price Return: 27.0%
- 5-Year Price Return: 78.5%
Visit the Passiv Stock Directory
Data provided by IEX Cloud
For Canadian securities, listen to free conference calls on the TSX Quarterly Podcast